149 related articles for article (PubMed ID: 36674469)
21. Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304).
Hong CY; Kim YK; Chang JH; Kim SH; Choi H; Nam DH; Kim YZ; Kwak JH
J Med Chem; 1997 Oct; 40(22):3584-93. PubMed ID: 9357525
[TBL] [Abstract][Full Text] [Related]
22. Pyrimidine-conjugated fluoroquinolones as new potential broad-spectrum antibacterial agents.
Tan YM; Li D; Li FF; Fawad Ansari M; Fang B; Zhou CH
Bioorg Med Chem Lett; 2022 Oct; 73():128885. PubMed ID: 35835379
[TBL] [Abstract][Full Text] [Related]
23. Adjuvants Based on Hybrid Antibiotics Overcome Resistance in Pseudomonas aeruginosa and Enhance Fluoroquinolone Efficacy.
Gorityala BK; Guchhait G; Fernando DM; Deo S; McKenna SA; Zhanel GG; Kumar A; Schweizer F
Angew Chem Int Ed Engl; 2016 Jan; 55(2):555-9. PubMed ID: 26610184
[TBL] [Abstract][Full Text] [Related]
24. [Synthesis and antibacterial activity of N-(aroylalkyl) ciprofloxacin].
Hu AX; Wang YT; You TB
Yao Xue Xue Bao; 2007 Aug; 42(8):854-7. PubMed ID: 17944234
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of fluoroquinolones containing a pyridoxine derivatives moiety.
Shtyrlin NV; Kayumov AR; Agafonova MN; Garipov MR; Gatina AE; Pugachev MV; Bulatova ES; Grishaev DY; Iksanova AG; Khaziev RM; Ganiev IM; Aimaletdinov AM; Gnezdilov OI; Shtyrlin YG
Eur J Med Chem; 2023 Dec; 261():115798. PubMed ID: 37729692
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of aryl fluoroquinolones, Abbott 56619 and Abbott 56620, compared to ciprofloxacin, norfloxacin and beta-lactams versus multidrug-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
Meyer RD; Liu S
Chemotherapy; 1986; 32(5):425-30. PubMed ID: 3093154
[TBL] [Abstract][Full Text] [Related]
27. Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.
Hardy DJ; Swanson RN; Hensey DM; Ramer NR; Bower RR; Hanson CW; Chu DT; Fernandes PB
Antimicrob Agents Chemother; 1987 Nov; 31(11):1768-74. PubMed ID: 3435123
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
Ibrahim NM; Fahim SH; Hassan M; Farag AE; Georgey HH
Eur J Med Chem; 2022 Jan; 228():114021. PubMed ID: 34871841
[TBL] [Abstract][Full Text] [Related]
29. Comparative quantification of the in vitro activity of veterinary fluoroquinolones.
Grobbel M; Lübke-Becker A; Wieler LH; Froyman R; Friederichs S; Filios S
Vet Microbiol; 2007 Sep; 124(1-2):73-81. PubMed ID: 17498893
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756).
Hayashi K; Takahata M; Kawamura Y; Todo Y
Arzneimittelforschung; 2002; 52(12):903-13. PubMed ID: 12572531
[TBL] [Abstract][Full Text] [Related]
31. [Studies on pyridonecarboxylic acids as antibacterial agents. XII. Synthesis and antibacterial activity of 6-chloro-1-cyclopropyl-7-(1-piperazinyl)-1, 4-dihydro-4-oxo-quinoline-3-carboxylic acid and analogues].
Li XH; Tian ZM; Miao H; Yu LX; Guo HY
Yao Xue Xue Bao; 1997 Nov; 32(11):844-51. PubMed ID: 11596203
[TBL] [Abstract][Full Text] [Related]
32. Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!
Jones RN; Beach ML; Pfaller MA
Diagn Microbiol Infect Dis; 2001 Nov; 41(3):161-3. PubMed ID: 11750171
[TBL] [Abstract][Full Text] [Related]
33. In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions.
Stubbings W; Leow P; Yong GC; Goh F; Körber-Irrgang B; Kresken M; Endermann R; Labischinski H
Antimicrob Agents Chemother; 2011 Sep; 55(9):4394-7. PubMed ID: 21709094
[TBL] [Abstract][Full Text] [Related]
34. [Studies on quinolone antibacterials. I. Synthesis and antibacterial activity of 7-(2-aminoethoxy)-, 7-(2-aminoethylthio)-, and 7-(2-aminoethylamino)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo qui noline -3-carboxylic acids and their derivatives].
Yoshida T; Yamamoto Y; Yagi N; Yasuda S; Katoh H; Itoh Y
Yakugaku Zasshi; 1990 Apr; 110(4):258-67. PubMed ID: 2198342
[TBL] [Abstract][Full Text] [Related]
35. Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99).
Jones RN; Pfaller MA;
Diagn Microbiol Infect Dis; 2001 Apr; 39(4):237-43. PubMed ID: 11404067
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent.
Guinea J; Robert M; Gargallo-Viola D; Xicota MA; Garcia J; Tudela E; Esteve M; Coll R; Pares M; Roser R
Antimicrob Agents Chemother; 1993 Apr; 37(4):868-74. PubMed ID: 8388202
[TBL] [Abstract][Full Text] [Related]
37. In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosa.
Thompson KD; O'Keefe JP; Tatarowicz WA
Antimicrob Agents Chemother; 1984 Aug; 26(2):275-6. PubMed ID: 6435518
[TBL] [Abstract][Full Text] [Related]
38. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
Lee YJ; Liu HY; Lin YC; Sun KL; Chun CL; Hsueh PR
Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
[TBL] [Abstract][Full Text] [Related]
39. Allicin-inspired thiolated fluoroquinolones as antibacterials against ESKAPE pathogens.
Sheppard JG; Long TE
Bioorg Med Chem Lett; 2016 Nov; 26(22):5545-5549. PubMed ID: 27756563
[TBL] [Abstract][Full Text] [Related]
40. Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.
Gargallo-Viola D; Ferrer S; Tudela E; Robert M; Coll R; Roser R; Guinea J
Antimicrob Agents Chemother; 2001 Nov; 45(11):3113-21. PubMed ID: 11600365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
